{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:47:06Z","timestamp":1786996026922,"version":"build-2736575974"},"reference-count":155,"publisher":"Elsevier BV","issue":"8-9","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progr\u00e8s en Urologie"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.purol.2020.11.004","type":"journal-article","created":{"date-parts":[[2021,4,30]],"date-time":"2021-04-30T08:37:11Z","timestamp":1619771831000},"page":"477-494","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Recommandations pour l\u2019\u00e9valuation et la prise en charge de la maladie de Lapeyronie\u00a0: rapport du comit\u00e9 d\u2019andrologie et de m\u00e9decine sexuelle de l\u2019AFU"],"prefix":"10.1016","volume":"31","author":[{"given":"L.","family":"Ferretti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.-X.","family":"Madec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Akakpo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Methorst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Carnicelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-E.","family":"Terrier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Morel Journel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Beley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-P.","family":"Graziana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Marcelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Hupertan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Yiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Ben-Naoum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Savareux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Huyghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Faix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.purol.2020.11.004_bib0780","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1111\/j.1743-6109.2007.00614.x","article-title":"Peyronie's disease (CME)","volume":"4","author":"Bella","year":"2007","journal-title":"The Journal of Sexual Medicine"},{"key":"10.1016\/j.purol.2020.11.004_bib0785","first-page":"12","article-title":"2018\u00a0Canadian Urological Association guideline for Peyronie's disease and congenital penile curvature","author":"Bella","year":"2018","journal-title":"Canadian Urological Association Journal"},{"key":"10.1016\/j.purol.2020.11.004_bib0790","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.jsxm.2016.04.062","article-title":"Evidence-Based Management Guidelines on Peyronie's Disease","volume":"13","author":"Chung","year":"2016","journal-title":"The Journal of Sexual Medicine"},{"key":"10.1016\/j.purol.2020.11.004_bib0795","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.jsxm.2018.01.025","article-title":"A Worldwide Survey on Peyronie's Disease Surgical Practice Patterns Among Surgeons","volume":"15","author":"Chung","year":"2018","journal-title":"J Sex Med"},{"key":"10.1016\/j.purol.2020.11.004_bib0800","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.eururo.2012.05.040","article-title":"EAU guidelines on penile curvature","volume":"62","author":"Hatzimouratidis","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.purol.2020.11.004_bib0805","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.juro.2015.05.098","article-title":"Peyronie's Disease: AUA Guideline","volume":"194","author":"Nehra","year":"2015","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2020.11.004_bib0810","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1097\/01.ju.0000127744.18878.f1","article-title":"Subjective and objective analysis of the prevalence of Peyronie's disease in a population of men presenting for prostate cancer screening","volume":"171","author":"Mulhall","year":"2004","journal-title":"The Journal of Urology"},{"key":"10.1016\/j.purol.2020.11.004_bib0815","doi-asserted-by":"crossref","first-page":"3572","DOI":"10.1111\/j.1743-6109.2010.02062.x","article-title":"Summary of the recommendations on sexual dysfunctions in men","volume":"7","author":"Montorsi","year":"2010","journal-title":"J Sex Med"},{"key":"10.1016\/j.purol.2020.11.004_bib0820","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1111\/j.1743-6109.2009.01655.x","article-title":"Peyronie's disease following radical prostatectomy: incidence and predictors","volume":"7","author":"Tal","year":"2010","journal-title":"J Sex Med"},{"key":"10.1016\/j.purol.2020.11.004_bib0825","first-page":"326","article-title":"The natural history of Peyronie's disease","volume":"60","author":"Grasso","year":"2007","journal-title":"Archivos Espanoles De Urologia"},{"key":"10.1016\/j.purol.2020.11.004_bib0830","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.eururo.2006.05.002","article-title":"Alterations in the transforming growth factor (TGF)-beta pathway as a potential factor in the pathogenesis of Peyronie's disease","volume":"51","author":"Haag","year":"2007","journal-title":"European Urology"},{"issue":"Suppl 5","key":"10.1016\/j.purol.2020.11.004_bib0835","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1038\/sj.ijir.3901082","article-title":"Expanding the paradigm for plaque development in Peyronie's disease","volume":"15","author":"Mulhall","year":"2003","journal-title":"International Journal of Impotence Research"},{"key":"10.1016\/j.purol.2020.11.004_bib0840","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1743-6109.2008.01104.x","article-title":"Experimental models of Peyronie's disease. Implications for new th\u00e9rapies","volume":"6","author":"Gonzalez-Cadavid","year":"2009","journal-title":"The Journal of Sexual Medicine"},{"key":"10.1016\/j.purol.2020.11.004_bib0845","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/S0022-5347(06)00270-9","article-title":"An analysis of the natural history of Peyronie's disease","volume":"175","author":"Mulhall","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2020.11.004_bib0850","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/sj.ijir.3900874","article-title":"Peyronie's disease cell culture models: phenotypic, genotypic and functional analyses","volume":"14","author":"Mulhall","year":"2002","journal-title":"International Journal of Impotence Research"},{"key":"10.1016\/j.purol.2020.11.004_bib0855","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/00005392-200102000-00016","article-title":"Basic fibroblast growth factor expression in Peyronie's disease","volume":"165","author":"Mulhall","year":"2001","journal-title":"The Journal of Urology"},{"key":"10.1016\/j.purol.2020.11.004_bib0860","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.urology.2005.01.010","article-title":"Peyronie's disease associated with increase in plasminogen activator inhibitor in fibrotic plaque","volume":"65","author":"Davila","year":"2005","journal-title":"Urology"},{"key":"10.1016\/j.purol.2020.11.004_bib0865","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1365-2605.2007.00780.x","article-title":"Repeated intratunical injection of adenovirus expressing transforming growth factor-beta1\u00a0in a rat induces penile curvature with tunical fibrotic plaque: a useful model for the study of Peyronie's disease","volume":"31","author":"Piao","year":"2008","journal-title":"International Journal of Andrology"},{"key":"10.1016\/j.purol.2020.11.004_bib0870","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/j.1939-4640.1998.tb02469.x","article-title":"Transforming growth factor-beta1 (TGF-beta1) in penile and prostate growth in the rat during sexual maturation","volume":"19","author":"Gelman","year":"1998","journal-title":"Journal of Andrology"},{"key":"10.1016\/j.purol.2020.11.004_bib0875","doi-asserted-by":"crossref","unstructured":"Lin G, Shindel AW, Banie L, Ning H, Huang YC, Liu G, et al. Pentoxifylline attenuates transforming growth factor-beta1-stimulated elastogenesis in human tunica albuginea-derived fibroblasts part 2: Interference in a TGF-beta1\/Smad-dependent mechanism and downregulation of AAT1. J Sex Med 7:1787-97. 10.1111\/j.1743-6109.2010.01749.x.","DOI":"10.1111\/j.1743-6109.2010.01749.x"},{"key":"10.1016\/j.purol.2020.11.004_bib0880","doi-asserted-by":"crossref","unstructured":"Shindel AW, Lin G, Ning H, Banie L, Huang YC, Liu G, et al. Pentoxifylline attenuates transforming growth factor-beta1-stimulated collagen deposition and elastogenesis in human tunica albuginea-derived fibroblasts part 1: impact on extracellular matrix. J Sex Med 7:2077-85. 10.1111\/j.1743-6109.2010.01790.x.","DOI":"10.1111\/j.1743-6109.2010.01790.x"},{"key":"10.1016\/j.purol.2020.11.004_bib0885","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/S0022-5347(01)64223-X","article-title":"Peyronie's disease is associated with an increase in transforming growth factor-beta protein expression","volume":"158","author":"El-Sakka","year":"1997","journal-title":"The Journal of Urology"},{"key":"10.1016\/j.purol.2020.11.004_bib0890","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/S0006-291X(02)00765-9","article-title":"Upregulation of monocyte chemoattractant protein 1\u00a0and effects of transforming growth factor-beta 1\u00a0in Peyronie's disease","volume":"295","author":"Lin","year":"2002","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.purol.2020.11.004_bib0895","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0022-5347(17)37988-0","article-title":"The incidence of Peyronie's disease in Rochester, Minnesota, 1950\u00a0through 1984","volume":"146","author":"Lindsay","year":"1991","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2020.11.004_bib0900","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/sj.ijir.3900863","article-title":"Epidemiology of Peyronie's disease","volume":"14","author":"Sommer","year":"2002","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.purol.2020.11.004_bib0905","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/S0022-5347(05)64578-8","article-title":"A retrospective review of 307\u00a0men with Peyronie's disease","volume":"168","author":"Kadioglu","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2020.11.004_bib0910","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1111\/j.1743-6109.2009.01584.x","article-title":"A cross-sectional study for the analysis of clinical, sexual and laboratory conditions associated to Peyronie's disease","volume":"7","author":"Rhoden","year":"2010","journal-title":"J Sex Med"},{"key":"10.1016\/j.purol.2020.11.004_bib0915","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/j.1464-410X.2006.05969.x","article-title":"Risk factors for Peyronie's disease: a case-control study","volume":"97","author":"Bjekic","year":"2006","journal-title":"BJU Int"},{"key":"10.1016\/j.purol.2020.11.004_bib0920","doi-asserted-by":"crossref","unstructured":"Ralph D, Gonzalez-Cadavid N, Mirone V, Perovic S, Sohn M, Usta M, et al. The management of Peyronie's disease: evidence-based 2010\u00a0guidelines. J Sex Med 7:2359-74. 10.1111\/j.1743-6109.2010.01850.x","DOI":"10.1111\/j.1743-6109.2010.01850.x"},{"key":"10.1016\/j.purol.2020.11.004_bib0925","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.eururo.2007.07.013","article-title":"The natural history of Peyronie's disease: an ultrasonography-based study","volume":"53","author":"Bekos","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.purol.2020.11.004_bib0930","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1743-6109.2004.10116.x","article-title":"Peyronie's disease","volume":"1","author":"Pryor","year":"2004","journal-title":"J Sex Med"},{"key":"10.1016\/j.purol.2020.11.004_bib0935","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1111\/j.1743-6109.2007.00600.x","article-title":"Validation of the erection hardness score","volume":"4","author":"Mulhall","year":"2007","journal-title":"J Sex Med"},{"key":"10.1016\/j.purol.2020.11.004_bib0940","doi-asserted-by":"crossref","first-page":"89","DOI":"10.5534\/wjmh.2016.34.2.89","article-title":"Modifying Risk Factors in the Management of Erectile Dysfunction: A Review","volume":"34","author":"DeLay","year":"2016","journal-title":"World J Mens Health"},{"key":"10.1016\/j.purol.2020.11.004_bib0945","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/jsm.12769","article-title":"The test-retest reliability of the Peyronie's disease questionnaire","volume":"12","author":"Coyne","year":"2015","journal-title":"J Sex Med"},{"key":"10.1016\/j.purol.2020.11.004_bib0950","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1111\/j.1743-6109.2008.00883.x","article-title":"Impact of Peyronie's disease on sexual and psychosocial functioning: qualitative findings in patients and controls","volume":"5","author":"Rosen","year":"2008","journal-title":"J Sex Med"},{"key":"10.1016\/j.purol.2020.11.004_bib0955","doi-asserted-by":"crossref","first-page":"290","DOI":"10.21037\/tau.2016.05.14","article-title":"Psychological aspects of Peyronie's disease","volume":"5","author":"Terrier","year":"2016","journal-title":"Transl Androl Urol"},{"key":"10.1016\/j.purol.2020.11.004_bib0960","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.jsxm.2016.04.074","article-title":"Female Partners of Men With Peyronie's Disease Have Impaired Sexual Function, Satisfaction, and Mood, While Degree of Sexual Interference Is Associated With Worse Outcomes","volume":"13","author":"Davis","year":"2016","journal-title":"J Sex Med"},{"issue":"Suppl 5","key":"10.1016\/j.purol.2020.11.004_bib0965","doi-asserted-by":"crossref","first-page":"S103","DOI":"10.1038\/sj.ijir.3901083","article-title":"Establishing a standardized evaluation of the man with Peyronie's disease","volume":"15","author":"Levine","year":"2003","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.purol.2020.11.004_bib0970","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1743-6109.2006.00404.x","article-title":"Measurement of penile curvature in Peyronie's disease patients: comparison of three methods","volume":"4","author":"Ohebshalom","year":"2007","journal-title":"J Sex Med"},{"key":"10.1016\/j.purol.2020.11.004_bib0975","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.juro.2013.01.090","article-title":"Bother and distress associated with Peyronie's disease: validation of the Peyronie's disease questionnaire","volume":"190","author":"Hellstrom","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2020.11.004_bib0980","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/sj.ijir.3900569","article-title":"Color Doppler ultrasound assessment of penile vascular system in men with Peyronie's disease","volume":"12","author":"Kadio\u011flu","year":"2000","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.purol.2020.11.004_bib0985","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1111\/j.1464-410X.2011.10851.x","article-title":"Penile Doppler sonographic and clinical characteristics in Peyronie's disease and\/or erectile dysfunction: an analysis of 1500\u00a0men with male sexual dysfunction","volume":"110","author":"Chung","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.purol.2020.11.004_bib0990","doi-asserted-by":"crossref","first-page":"469","DOI":"10.5694\/mja2.50167","article-title":"Current diagnosis and management of erectile dysfunction","volume":"210","author":"McMahon","year":"2019","journal-title":"Med J Aust"},{"key":"10.1016\/j.purol.2020.11.004_bib0995","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/andr.292","article-title":"Peyronie's disease: urologist's knowledge base and practice patterns","volume":"3","author":"Sullivan","year":"2015","journal-title":"Andrology"},{"key":"10.1016\/j.purol.2020.11.004_bib1000","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.juro.2015.05.098","article-title":"Peyronie's Disease: AUA Guideline","volume":"194","author":"Nehra","year":"2015","journal-title":"The Journal of Urology"},{"key":"10.1016\/j.purol.2020.11.004_bib1005","article-title":"[Non-surgical management of Peyronie's disease: State of current knowledge]","author":"Abdessater","year":"2020","journal-title":"Prog Urol"},{"key":"10.1016\/j.purol.2020.11.004_bib1010","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.eururo.2004.12.022","article-title":"Potassium Paraaminobenzoate (POTABA\u2122) in the Treatment of Peyronie's Disease: A Prospective, Placebo-Controlled, Randomized Study","volume":"47","author":"Weidner","year":"2005","journal-title":"European Urology"},{"key":"10.1016\/j.purol.2020.11.004_bib1015","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1016\/j.ejca.2009.05.015","article-title":"Pentoxifylline and vitamin E treatment for prevention of radiation-induced side-effects in women with breast cancer: A phase two, double-blind, placebo-controlled randomised clinical trial (Ptx-5)","volume":"45","author":"Magnusson","year":"2009","journal-title":"European Journal of Cancer"},{"key":"10.1016\/j.purol.2020.11.004_bib1020","doi-asserted-by":"crossref","first-page":"397","DOI":"10.2164\/jandrol.108.006221","article-title":"Medical Management of Peyronie's Disease","volume":"30","author":"Hellstrom","year":"2009","journal-title":"Journal of Andrology"},{"key":"10.1016\/j.purol.2020.11.004_bib1025","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.eururo.2006.02.059","article-title":"A Critical Analysis of Nonsurgical Treatment of Peyronie's Disease","volume":"49","author":"Hauck","year":"2006","journal-title":"European Urology"},{"key":"10.1016\/j.purol.2020.11.004_bib1030","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1046\/j.1464-410X.2003.04134.x","article-title":"Combined treatment with vitamin E and colchicine in the early stages of Peyronie's disease","volume":"91","author":"Prieto Castro","year":"2003","journal-title":"BJU Int"},{"key":"10.1016\/j.purol.2020.11.004_bib1035","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1093\/ajcn\/73.2.219","article-title":"A controlled clinical trial of vitamin E supplementation in patients with congestive heart failure","volume":"73","author":"Keith","year":"2001","journal-title":"The American Journal of Clinical Nutrition"},{"key":"10.1016\/j.purol.2020.11.004_bib1040","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1442-2042.2006.01270.x","article-title":"Outcome analysis for conservative management of Peyronie's disease: Conservative management of Peyronie's disease","volume":"13","author":"Hashimoto","year":"2006","journal-title":"International Journal of Urology"},{"key":"10.1016\/j.purol.2020.11.004_bib1045","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.urology.2005.11.005","article-title":"Effect of intralesional interferon-alpha 2b combined with oral vitamin E for treatment of early stage Peyronie's disease: A randomized and prospective study","volume":"67","author":"Inal","year":"2006","journal-title":"Urology"},{"key":"10.1016\/j.purol.2020.11.004_bib1050","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/j.juro.2007.05.162","article-title":"Comparison of Vitamin E and Propionyl-L-Carnitine, Separately or in Combination, in Patients With Early Chronic Peyronie's Disease: A Double-Blind, Placebo Controlled, Randomized Study","volume":"178","author":"Safarinejad","year":"2007","journal-title":"The Journal of Urology"},{"key":"10.1016\/j.purol.2020.11.004_bib1055","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.2047-2927.2012.00007.x","article-title":"Efficacy of vitamin E in the conservative treatment of Peyronie's disease: legend or reality?. A controlled study of 70\u00a0cases","volume":"1","author":"Paulis","year":"2013","journal-title":"Andrology"},{"key":"10.1016\/j.purol.2020.11.004_bib1060","doi-asserted-by":"crossref","first-page":"158","DOI":"10.2174\/1874609811104020158","article-title":"Vitamin E and all-cause mortality: a meta-analysis","volume":"4","author":"Abner","year":"2011","journal-title":"Curr Aging Sci"},{"key":"10.1016\/j.purol.2020.11.004_bib1065","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/bju.12634","article-title":"Minimally invasive treatment of Peyronie's disease: evidence-based progress: Minimally invasive treatment of Peyronie's disease","volume":"114","author":"Jordan","year":"2014","journal-title":"BJU Int"},{"key":"10.1016\/j.purol.2020.11.004_bib1070","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0090-4295(94)80155-X","article-title":"Is colchicine effective in Peyronie's disease? A pilot study","volume":"44","author":"Akkus","year":"1994","journal-title":"Urology"},{"key":"10.1016\/j.purol.2020.11.004_bib1075","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/sj.ijir.3900519","article-title":"Treatment of Peyronie's disease with oral colchicine: long-term results and predictive parameters of successful outcome","volume":"12","author":"Kadio\u011flu","year":"2000","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.purol.2020.11.004_bib1080","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/sj.ijir.3901185","article-title":"Therapeutic effects of colchicine in the management of Peyronie's disease: a randomized double-blind, placebo-controlled study","volume":"16","author":"Safarinejad","year":"2004","journal-title":"International Journal of Impotence Research"},{"key":"10.1016\/j.purol.2020.11.004_bib1085","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.ejim.2010.09.010","article-title":"Colchicine in clinical medicine. A guide for internists","volume":"21","author":"Cocco","year":"2010","journal-title":"European Journal of Internal Medicine"},{"key":"10.1016\/j.purol.2020.11.004_bib1090","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.eururo.2012.05.040","article-title":"EAU Guidelines on Penile Curvature","volume":"62","author":"Hatzimouratidis","year":"2012","journal-title":"European Urology"},{"key":"10.1016\/j.purol.2020.11.004_bib1095","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/j.1464-410X.1992.tb15836.x","article-title":"The treatment of Peyronie's disease with tamoxifen","volume":"70","author":"Ralph","year":"1992","journal-title":"Br J Urol"},{"key":"10.1016\/j.purol.2020.11.004_bib1100","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1016\/S0022-5347(05)68087-1","article-title":"Tamoxifen versus placebo in the treatment of Peyronie's disease","volume":"162","author":"Teloken","year":"1999","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2020.11.004_bib1105","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1111\/j.1743-6109.2010.01749.x","article-title":"Pentoxifylline Attenuates Transforming Growth Factor-\u03b21-Stimulated Elastogenesis in Human Tunica Albuginea-Derived Fibroblasts Part 2: Interference in a TGF-\u03b21\/Smad-Dependent Mechanism and Downregulation of AAT1","volume":"7","author":"Lin","year":"2010","journal-title":"The Journal of Sexual Medicine"},{"key":"10.1016\/j.purol.2020.11.004_bib1110","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.esxm.2019.07.003","article-title":"Evaluation of Oral Pentoxifylline, Colchicine, and Penile Traction for the Management of Peyronie's Disease","volume":"7","author":"Ibrahim","year":"2019","journal-title":"Sex Med"},{"key":"10.1016\/j.purol.2020.11.004_bib1115","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1464-410X.2009.09041.x","article-title":"A double-blind placebo-controlled study of the efficacy and safety of pentoxifylline in early chronic Peyronie's disease: PENTOXIFYLLINE IN EARLY PEYRONIE'S DISEASE","volume":"106","author":"Safarinejad","year":"2009","journal-title":"BJU International"},{"key":"10.1016\/j.purol.2020.11.004_bib1120","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/aja.2010.117","article-title":"Pentoxifylline treatment and penile calcifications in men with Peyronie's disease","volume":"13","author":"Smith","year":"2011","journal-title":"Asian Journal of Andrology"},{"key":"10.1016\/j.purol.2020.11.004_bib1125","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.sexol.2018.01.009","article-title":"Les traitements oraux de la dysfonction \u00e9rectile aujourd\u2019hui, pour quel patient\u00a0?","volume":"27","author":"Colson","year":"2018","journal-title":"Sexologies"},{"key":"10.1016\/j.purol.2020.11.004_bib1130","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/s41443-018-0029-3","article-title":"The relationship between penile deformity, age, psychological bother, and erectile dysfunction in a sample of men with Peyronie's Disease (PD)","volume":"30","author":"Burri","year":"2018","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.purol.2020.11.004_bib1135","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/sj.ijir.3900912","article-title":"Treatment of erectile dysfunction in patients with Peyronie's disease using sildenafil citrate","volume":"14","author":"Levine","year":"2002","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.purol.2020.11.004_bib1140","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s11845-013-1036-5","article-title":"Effects of sildenafil treatment on patients with Peyronie's disease and erectile dysfunction","volume":"183","author":"Ozturk","year":"2014","journal-title":"Ir J Med Sci"},{"key":"10.1016\/j.purol.2020.11.004_bib1145","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1365-2605.2011.01226.x","article-title":"Tadalafil once daily and extracorporeal shock wave therapy in the management of patients with Peyronie's disease and erectile dysfunction: results from a prospective randomized trial","volume":"35","author":"Palmieri","year":"2012","journal-title":"Int J Androl"},{"key":"10.1016\/j.purol.2020.11.004_bib1150","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1016\/j.jsxm.2018.08.012","article-title":"Sildenafil 25mg ODT\u00a0+ Collagenase Clostridium hystoliticum vs Collagenase Clostridium hystoliticum Alone for the Management of Peyronie's Disease: A Matched-Pair Comparison Analysis","volume":"15","author":"Cocci","year":"2018","journal-title":"J Sex Med"},{"key":"10.1016\/j.purol.2020.11.004_bib1155","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nrurol.2010.24","article-title":"Treatment of Peyronie's disease with PDE5\u00a0inhibitors: an antifibrotic strategy","volume":"7","author":"Gonzalez-Cadavid","year":"2010","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.purol.2020.11.004_bib1160","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1111\/j.1743-6109.2011.02217.x","article-title":"The role of PDE5\u00a0inhibitors in penile septal scar remodeling: assessment of clinical and radiological outcomes","volume":"8","author":"Chung","year":"2011","journal-title":"J Sex Med"},{"key":"10.1016\/j.purol.2020.11.004_bib1165","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.juro.2018.05.004","article-title":"Erectile Dysfunction: AUA Guideline","volume":"200","author":"Burnett","year":"2018","journal-title":"Journal of Urology"},{"key":"10.1016\/j.purol.2020.11.004_bib1170","doi-asserted-by":"crossref","first-page":"S269","DOI":"10.21037\/tau.2019.08.06","article-title":"Minimally invasive th\u00e9rapies for Peyronie's disease: the current state of the art","volume":"9","author":"Farrell","year":"2020","journal-title":"Translational Andrology and Urology"},{"key":"10.1016\/j.purol.2020.11.004_bib1175","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/bju.13096","article-title":"Clinical efficacy of collagenase Clostridium histolyticum in the treatment of Peyronie's disease by subgroup: results from two large, double-blind, randomized, placebo-controlled, phase III studies","volume":"116","author":"Lipshultz","year":"2015","journal-title":"BJU Int"},{"key":"10.1016\/j.purol.2020.11.004_bib1180","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.juro.2013.01.087","article-title":"Clinical efficacy, safety and tolerability of collagenase clostridium histolyticum for the treatment of peyronie disease in 2\u00a0large double-blind, randomized, placebo controlled phase 3\u00a0studies","volume":"190","author":"Gelbard","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2020.11.004_bib1185","first-page":"291","article-title":"Evaluation of intralesional injection of verapamil in treatment of Peyronie's disease","volume":"60","author":"Heidari","year":"2010","journal-title":"J Pak Med Assoc"},{"key":"10.1016\/j.purol.2020.11.004_bib1190","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1111\/j.1464-410X.2010.10029.x","article-title":"Defining predictors of response to intralesional verapamil injection therapy for Peyronie's disease","volume":"108","author":"Moskovic","year":"2011","journal-title":"BJU Int"},{"key":"10.1016\/j.purol.2020.11.004_bib1195","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.urology.2007.02.042","article-title":"Intralesional verapamil prevents the progression of Peyronie's disease","volume":"69","author":"Bennett","year":"2007","journal-title":"Urology"},{"key":"10.1016\/j.purol.2020.11.004_bib1200","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.urology.2015.03.010","article-title":"Intralesional Injections for Early Peyronie Disease: Standardized Assessment and Analysis of Predictive Factors for Treatment Response","volume":"86","author":"Wolff","year":"2015","journal-title":"Urology"},{"key":"10.1016\/j.purol.2020.11.004_bib1205","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s11255-009-9522-4","article-title":"Effect of intralesional verapamil for treatment of Peyronie's disease: a randomized single-blind, placebo-controlled study","volume":"41","author":"Shirazi","year":"2009","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.purol.2020.11.004_bib1210","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S0090-4295(97)00700-0","article-title":"Use of intralesional verapamil to dissolve Peyronie's disease plaque: a long-term single-blind study","volume":"51","author":"Rehman","year":"1998","journal-title":"Urology"},{"key":"10.1016\/j.purol.2020.11.004_bib1215","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/j.1939-4640.1999.tb02539.x","article-title":"A pilot study demonstrating clinical benefit from intralesional interferon alpha 2B in the treatment of Peyronie's disease","volume":"20","author":"Ahuja","year":"1999","journal-title":"J Androl"},{"key":"10.1016\/j.purol.2020.11.004_bib1220","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S0022-5347(06)00517-9","article-title":"Single-blind, multicenter, placebo controlled, parallel study to assess the safety and efficacy of intralesional interferon alpha-2B for minimally invasive treatment for Peyronie's disease","volume":"176","author":"Hellstrom","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2020.11.004_bib1225","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/S0022-5347(17)67169-6","article-title":"Peyronie's disease: results with dermo-jet injection of dexamethasone","volume":"114","author":"Winter","year":"1975","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2020.11.004_bib1230","first-page":"165","article-title":"[Betamethasone versus placebo in Peyronie's disease]","volume":"70","author":"Cipollone","year":"1998","journal-title":"Arch Ital Urol Androl"},{"key":"10.1016\/j.purol.2020.11.004_bib1235","doi-asserted-by":"crossref","first-page":"e13051","DOI":"10.1111\/and.13051","article-title":"Reduction in Peyronie's-like plaque size using a vacuum erection device in a rat model of Peyronie's disease via the TGF-\u03b2\/SMAD signalling pathway","volume":"50","author":"Li","year":"2018","journal-title":"Andrologia"},{"key":"10.1016\/j.purol.2020.11.004_bib1240","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1111\/jsm.12082","article-title":"Peyronie's Disease and Mechanotransduction: An In Vitro Analysis of the Cellular Changes to Peyronie's Disease in a Cell-Culture Strain System","volume":"10","author":"Chung","year":"2013","journal-title":"The Journal of Sexual Medicine"},{"key":"10.1016\/j.purol.2020.11.004_bib1245","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.eururo.2010.07.005","article-title":"Molecular Mechanisms of Vacuum Therapy in Penile Rehabilitation: A Novel Animal Study","volume":"58","author":"Yuan","year":"2010","journal-title":"European Urology"},{"key":"10.1016\/j.purol.2020.11.004_bib1250","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/jsm.12400","article-title":"Acute Phase Peyronie's Disease Management with Traction Device: A Nonrandomized Prospective Controlled Trial with Ultrasound Correlation","volume":"11","author":"Mart\u00ednez-Salamanca","year":"2014","journal-title":"The Journal of Sexual Medicine"},{"key":"10.1016\/j.purol.2020.11.004_bib1255","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1111\/j.1743-6109.2008.00814.x","article-title":"Penile Traction Therapy for Treatment of Peyronie's Disease: A Single-Center Pilot Study","volume":"5","author":"Levine","year":"2008","journal-title":"The Journal of Sexual Medicine"},{"key":"10.1016\/j.purol.2020.11.004_bib1260","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/j.1743-6109.2008.01108.x","article-title":"Original research\u2014Peyronie's disease: Use of Penile Extender Device in the Treatment of Penile Curvature as a Result of Peyronie's Disease. Results of a Phase II Prospective Study","volume":"6","author":"Gontero","year":"2009","journal-title":"The Journal of Sexual Medicine"},{"key":"10.1016\/j.purol.2020.11.004_bib1265","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1111\/j.1464-410X.2010.09365.x","article-title":"The role of vacuum pump therapy to mechanically straighten the penis in Peyronie's disease: Vacuum pump therapy to straighten the penis in Peyronie's disease","volume":"106","author":"Raheem","year":"2010","journal-title":"BJU International"},{"key":"10.1016\/j.purol.2020.11.004_bib1270","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.eururo.2009.05.012","article-title":"A first prospective, randomized, double-blind, placebo-controlled clinical trial evaluating extracorporeal shock wave therapy for the treatment of Peyronie's disease","volume":"56","author":"Palmieri","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.purol.2020.11.004_bib1275","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0090-4295(02)01527-3","article-title":"Extracorporeal shock wave therapy in the treatment of Peyronie's disease: experience with standard lithotriptor (siemens-multiline)","volume":"59","author":"Lebret","year":"2002","journal-title":"Urology"},{"key":"10.1016\/j.purol.2020.11.004_bib1280","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/ijir.2016.24","article-title":"A meta-analysis of extracorporeal shock wave therapy for Peyronie's disease","volume":"28","author":"Gao","year":"2016","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.purol.2020.11.004_bib1285","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1016\/j.jsxm.2019.07.016","article-title":"Low-Intensity Shock Wave Therapy in Sexual Medicine-Clinical Recommendations from the European Society of Sexual Medicine (ESSM)","volume":"16","author":"Capogrosso","year":"2019","journal-title":"J Sex Med"},{"key":"10.1016\/j.purol.2020.11.004_bib1290","unstructured":"Tsambarlis P, Levine LA. Nonsurgical management of Peyronie's disease n.d.:15."},{"key":"10.1016\/j.purol.2020.11.004_bib1295","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/j.1743-6109.2011.02519.x","article-title":"Combination of penile traction, intralesional verapamil, and oral th\u00e9rapies for Peyronie's disease","volume":"9","author":"Abern","year":"2012","journal-title":"J Sex Med"},{"key":"10.1016\/j.purol.2020.11.004_bib1300","first-page":"1430","article-title":"Treatment of Peyronie's Disease With Collagenase Clostridium histolyticum and Vacuum Therapy: A Randomized","volume":"14","author":"Ralph","year":"2017","journal-title":"Open-Label Pilot Study. J Sex Med"},{"key":"10.1016\/j.purol.2020.11.004_bib1305","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.juro.2015.03.092","article-title":"The Effect of Duration of Penile Traction Therapy in Patients Undergoing Intralesional Injection Therapy for Peyronie's Disease","volume":"194","author":"Yafi","year":"2015","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2020.11.004_bib1310","doi-asserted-by":"crossref","first-page":"e631","DOI":"10.1097\/GOX.0000000000000622","article-title":"Stromal Vascular Fraction Combined with Shock Wave for the Treatment of Peyronie's Disease","volume":"4","author":"Lander","year":"2016","journal-title":"Plast Reconstr Surg Glob Open"},{"key":"10.1016\/j.purol.2020.11.004_bib1315","doi-asserted-by":"crossref","first-page":"S295","DOI":"10.21037\/tau.2019.09.36","article-title":"Non-conventional th\u00e9rapies for Peyronie's disease: what is the evidence for efficacy?","volume":"9","author":"Aditya","year":"2020","journal-title":"Translational Andrology and Urology"},{"key":"10.1016\/j.purol.2020.11.004_bib1320","first-page":"e83","article-title":"Intralesional Injection of Hyaluronic Acid in Patients Affected With Peyronie's Disease: Preliminary Results From a Prospective, Multicenter, Pilot Study","volume":"4","author":"Zucchi","year":"2016","journal-title":"Sex Med"},{"key":"10.1016\/j.purol.2020.11.004_bib1325","first-page":"1","article-title":"Evaluation of the benefit of using a combination of autologous platelet rich-plasma and hyaluronic acid for the treatment of Peyronie's disease","author":"Virag","year":"2017","journal-title":"Sexual Health Issues"},{"key":"10.1016\/j.purol.2020.11.004_bib1330","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/andr.12368","article-title":"Evaluation of intralesional injection of hyaluronic acid compared with verapamil in Peyronie's disease: preliminary results from a prospective, double-blinded, randomized study","volume":"5","author":"Favilla","year":"2017","journal-title":"Andrology"},{"key":"10.1016\/j.purol.2020.11.004_bib1335","doi-asserted-by":"crossref","first-page":"61","DOI":"10.4111\/icu.2018.59.1.61","article-title":"Safety and feasibility of platelet rich fibrin matrix injections for treatment of common urologic conditions","volume":"59","author":"Matz","year":"2018","journal-title":"Investig Clin Urol"},{"key":"10.1016\/j.purol.2020.11.004_bib1340","first-page":"e8","article-title":"Effects of Stem Cell Treatment in Human Patients With Peyronie Disease","volume":"115","author":"Levy","year":"2015","journal-title":"J Am Osteopath Assoc"},{"key":"10.1016\/j.purol.2020.11.004_bib1345","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/ijir.2015.22","article-title":"Topical treatment for acute phase Peyronie's disease utilizing a new gel, H-100: a randomized, prospective, placebo-controlled pilot study","volume":"28","author":"Twidwell","year":"2016","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.purol.2020.11.004_bib1350","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.urology.2016.02.009","article-title":"Contemporary Review of Treatment Options for Peyronie's Disease","volume":"95","author":"Sherer","year":"2016","journal-title":"Urology"},{"key":"10.1016\/j.purol.2020.11.004_bib1355","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/sj.ijir.3901255","article-title":"Surgical treatment of Peyronie's disease based on penile length and degree of curvature","volume":"17","author":"Bokarica","year":"2005","journal-title":"International Journal of Impotence Research"},{"key":"10.1016\/j.purol.2020.11.004_bib1360","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ucl.2011.03.001","article-title":"Peyronie Disease: Plication or Grafting","volume":"38","author":"Langston","year":"2011","journal-title":"Urologic Clinics of North America"},{"key":"10.1016\/j.purol.2020.11.004_bib1365","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.purol.2013.02.012","article-title":"[Lapeyronie's disease]","volume":"23","author":"Ferretti","year":"2013","journal-title":"Prog Urol"},{"key":"10.1016\/j.purol.2020.11.004_bib1370","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0022-5347(17)63751-0","article-title":"Congenital curvature of the phallus: report of three cases with description of corrective operation","volume":"93","author":"Nesbit","year":"1965","journal-title":"The Journal of Urology"},{"key":"10.1016\/j.purol.2020.11.004_bib1375","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/S0022-5347(17)56530-1","article-title":"A new approach to the correction of the penile deformity in Peyronie's disease","volume":"122","author":"Pryor","year":"1979","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2020.11.004_bib1380","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/S0090-4295(02)02549-9","article-title":"Nesbit procedure for disabling Peyronie's curvature: a median follow-up of 84\u00a0months","volume":"61","author":"Syed","year":"2003","journal-title":"Urology"},{"key":"10.1016\/j.purol.2020.11.004_bib1385","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/0090-4295(85)90285-7","article-title":"New surgical treatment for Peyronie disease","volume":"25","author":"Essed","year":"1985","journal-title":"Urology"},{"key":"10.1016\/j.purol.2020.11.004_bib1390","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/S0022-5347(01)66862-9","article-title":"The Nesbit operation for Peyronie's disease: 16-year experience","volume":"154","author":"Ralph","year":"1995","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2020.11.004_bib1395","doi-asserted-by":"crossref","first-page":"167","DOI":"10.4103\/0974-7796.115736","article-title":"Penile corporoplasty with Yachia's technique for Peyronie's disease: Single center experience with 117\u00a0patients","volume":"5","author":"Lopes","year":"2013","journal-title":"Urol Ann"},{"key":"10.1016\/j.purol.2020.11.004_bib1400","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.eururo.2007.04.045","article-title":"Surgical Treatment of Peyronie's Disease: A Single Center Experience with 145\u00a0Patients","volume":"53","author":"Kadioglu","year":"2008","journal-title":"European Urology"},{"key":"10.1016\/j.purol.2020.11.004_bib1405","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/j.1464-410X.1984.tb06156.x","article-title":"Nesbit's operation for Peyronie's disease","volume":"56","author":"Lemberger","year":"1984","journal-title":"BJU International"},{"key":"10.1016\/j.purol.2020.11.004_bib1410","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/S0022-5347(01)64953-X","article-title":"Results of surgical treatment for abnormal penile curvature: Peyronie's disease and congenital deviation by modified Nesbit plication (tunical shaving and plication)","volume":"157","author":"Rehman","year":"1997","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2020.11.004_bib1415","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0022-5347(05)00063-7","article-title":"Factors Affecting the Loss of Length Associated With Tunica Albuginea Plication for Correction of Penile Curvature","volume":"175","author":"Greenfield","year":"2006","journal-title":"The Journal of Urology"},{"key":"10.1016\/j.purol.2020.11.004_bib1420","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.eururo.2004.04.027","article-title":"Straightening Corporoplasty for Peyronie's Disease: A Review of 218\u00a0Patients with Median Follow-Up of 89\u00a0Months","volume":"46","author":"Savoca","year":"2004","journal-title":"European Urology"},{"key":"10.1016\/j.purol.2020.11.004_bib1425","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1007\/s00345-002-0307-y","article-title":"Treatment of penile curvature\u2013how to combine the advantages of simple plication and the Nesbit-procedure by superficial excision of the tunica albuginea","volume":"20","author":"Schneider","year":"2003","journal-title":"World Journal of Urology"},{"key":"10.1016\/j.purol.2020.11.004_bib1430","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.urology.2007.11.065","article-title":"Subjective Patient-Reported Experiences After Surgery for Peyronie's Disease: Corporeal Plication Versus Plaque Incision with Vein Graft","volume":"71","author":"Kim","year":"2008","journal-title":"Urology"},{"key":"10.1016\/j.purol.2020.11.004_bib1435","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/andr.12431","article-title":"Surgical correction of Peyronie's disease via tunica albuginea plication: long-term follow-up","volume":"6","author":"Seveso","year":"2018","journal-title":"Andrology"},{"key":"10.1016\/j.purol.2020.11.004_bib1440","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1464-410X.2009.08763.x","article-title":"Circumcision is not mandatory in penile surgery","volume":"105","author":"Garaffa","year":"2010","journal-title":"BJU International"},{"key":"10.1016\/j.purol.2020.11.004_bib1445","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1111\/j.1464-410X.2005.05459.x","article-title":"The results of plaque incision and venous grafting (Lue procedure) to correct the penile deformity of Peyronie's disease","volume":"95","author":"Kalsi","year":"2005","journal-title":"BJU Int"},{"key":"10.1016\/j.purol.2020.11.004_bib1450","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0022-5347(17)37941-7","article-title":"Venogenic impotence following dermal graft repair for Peyronie's disease","volume":"146","author":"Dalkin","year":"1991","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2020.11.004_bib1455","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/j.1743-6109.2007.00461.x","article-title":"Graft materials in Peyronie's disease surgery: a comprehensive review","volume":"4","author":"Kadioglu","year":"2007","journal-title":"J Sex Med"},{"key":"10.1016\/j.purol.2020.11.004_bib1460","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/j.1743-6109.2010.02102.x","article-title":"Five-year follow-up of Peyronie's graft surgery: outcomes and patient satisfaction","volume":"8","author":"Chung","year":"2011","journal-title":"J Sex Med"},{"key":"10.1016\/j.purol.2020.11.004_bib1465","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/andr.12421","article-title":"Grafts for Peyronie's disease: a comprehensive review","volume":"6","author":"Garcia-Gomez","year":"2018","journal-title":"Andrology"},{"key":"10.1016\/j.purol.2020.11.004_bib1470","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1743-6109.2012.03003.x","article-title":"Standard operating procedures for Peyronie's disease","volume":"10","author":"Levine","year":"2013","journal-title":"J Sex Med"},{"key":"10.1016\/j.purol.2020.11.004_bib1475","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1111\/j.1743-6109.2011.02299.x","article-title":"Erectile dysfunction after plaque incision and grafting: short-term assessment of incidence and predictors","volume":"8","author":"Flores","year":"2011","journal-title":"J Sex Med"},{"key":"10.1016\/j.purol.2020.11.004_bib1480","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1111\/j.1743-6109.2012.02849.x","article-title":"A retrospective comparative study of traction therapy vs. no traction following tunica albuginea plication or partial excision and grafting for Peyronie's disease: measured lengths and patient perceptions","volume":"9","author":"Rybak","year":"2012","journal-title":"J Sex Med"},{"key":"10.1016\/j.purol.2020.11.004_bib1485","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0022-5347(17)59886-9","article-title":"Surgical treatment of Peyronie's disease with a dermal graff","volume":"111","author":"Devine","year":"1974","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2020.11.004_bib1490","doi-asserted-by":"crossref","first-page":"186","DOI":"10.2164\/jandrol.106.000760","article-title":"Long-term results of autologous venous grafts for penile morphological reconstruction","volume":"28","author":"Hsu","year":"2007","journal-title":"J Androl"},{"key":"10.1016\/j.purol.2020.11.004_bib1495","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.eururo.2006.05.016","article-title":"The surgical treatment of Peyronie's disease","volume":"50","author":"Ralph","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.purol.2020.11.004_bib1500","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0022-5347(05)66106-X","article-title":"A comparison of dermal and cadaveric pericardial grafts in the modified Horton-Devine procedure for Peyronie's disease","volume":"166","author":"Chun","year":"2001","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2020.11.004_bib1505","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/S0022-5347(17)55682-7","article-title":"Peyronie's disease: excision and autografting with tunica vaginalis","volume":"124","author":"Das","year":"1980","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2020.11.004_bib1510","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.eururo.2008.11.041","article-title":"Surgical treatment of Peyronie's disease by plaque incision and grafting with buccal mucosa","volume":"55","author":"Cormio","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.purol.2020.11.004_bib1515","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.juro.2006.09.051","article-title":"Complications of porcine small intestine submucosa graft for Peyronie's disease","volume":"177","author":"Breyer","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2020.11.004_bib1520","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1016\/j.juro.2007.08.044","article-title":"Use of small intestinal submucosa graft for the surgical management of Peyronie's disease","volume":"178","author":"Knoll","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2020.11.004_bib1525","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s00345-019-02792-w","article-title":"Evolution of the surgical sealing patch TachoSil\u00ae in Peyronie's disease reconstructive surgery: technique and contemporary literature review","volume":"38","author":"Hatzichristodoulou","year":"2020","journal-title":"World J Urol"},{"key":"10.1016\/j.purol.2020.11.004_bib1530","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.purol.2019.11.011","article-title":"[Plaque incision and Tachosil graft in Peyronie's Disease]","volume":"30","author":"de Sallmard","year":"2020","journal-title":"Prog Urol"},{"key":"10.1016\/j.purol.2020.11.004_bib1535","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1743-6109.2005.20113.x","article-title":"A surgical algorithm for men with combined Peyronie's disease and erectile dysfunction: functional and satisfaction outcomes","volume":"2","author":"Mulhall","year":"2005","journal-title":"J Sex Med"},{"key":"10.1016\/j.purol.2020.11.004_bib1540","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1111\/bju.13371","article-title":"A prospective multicentric international study on the surgical outcomes and patients\u2019 satisfaction rates of the \u201csliding\u201d technique for end-stage Peyronie's disease with severe shortening of the penis and erectile dysfunction","volume":"117","author":"Rolle","year":"2016","journal-title":"BJU Int"},{"key":"10.1016\/j.purol.2020.11.004_bib1545","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/S0022-5347(17)32519-3","article-title":"A new treatment for Peyronie's disease: modeling the penis over an inflatable penile prosthesis","volume":"152","author":"Wilson","year":"1994","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2020.11.004_bib1550","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jsxm.2016.11.304","article-title":"Successful Placement of Penile Prostheses in Men With Severe Corporal Fibrosis Following Vacuum Therapy Protocol","volume":"14","author":"Tsambarlis","year":"2017","journal-title":"J Sex Med"}],"container-title":["Progr\u00e8s en Urologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1166708720306928?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1166708720306928?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T06:34:39Z","timestamp":1761114879000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1166708720306928"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":155,"journal-issue":{"issue":"8-9","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S1166708720306928"],"URL":"https:\/\/doi.org\/10.1016\/j.purol.2020.11.004","relation":{},"ISSN":["1166-7087"],"issn-type":[{"value":"1166-7087","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recommandations pour l\u2019\u00e9valuation et la prise en charge de la maladie de Lapeyronie\u00a0: rapport du comit\u00e9 d\u2019andrologie et de m\u00e9decine sexuelle de l\u2019AFU","name":"articletitle","label":"Article Title"},{"value":"Progr\u00e8s en Urologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.purol.2020.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}